Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging
- PMID: 17041012
- DOI: 10.1152/ajplung.00308.2006
Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging
Abstract
The silent information regulator 2 (Sir2) family of proteins (sirtuins or SIRTs), which belong to class III histone/protein deacetylases, have been implicated in calorie restriction, aging, and inflammation. We hypothesized that cigarette smoke-mediated proinflammatory cytokine release is regulated by SIRT1 by its interaction with NF-kappaB in a monocyte-macrophage cell line (MonoMac6) and in inflammatory cells of rat lungs. Cigarette smoke extract (CSE) exposure to MonoMac6 cells caused dose- and time-dependent decreases in SIRT1 activity and levels, which was concomitant to increased NF-kappaB-dependent proinflammatory mediator release. Similar decrements in SIRT1 were also observed in inflammatory cells in the lungs of rats exposed to cigarette smoke as well as with increased levels of several NF-kappaB-dependent proinflammatory mediators in bronchoalveolar lavage fluid and in lungs. Sirtinol, an inhibitor of SIRT1, augmented, whereas resveratrol, an activator of SIRT1, inhibited CSE-mediated proinflammatory cytokine release. CSE-mediated inhibition of SIRT1 was associated with increased NF-kappaB levels. Furthermore, we showed that SIRT1 interacts with the RelA/p65 subunit of NF-kappaB, which was disrupted by cigarette smoke, leading to increased acetylation RelA/p65 in MonoMac6 cells. Thus our data show that SIRT1 regulates cigarette smoke-mediated proinflammatory mediator release via NF-kappaB, implicating a role of SIRT1 in sustained inflammation and aging of the lungs.
Similar articles
-
SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008 Apr 15;177(8):861-70. doi: 10.1164/rccm.200708-1269OC. Epub 2008 Jan 3. Am J Respir Crit Care Med. 2008. PMID: 18174544 Free PMC article.
-
Erythromycin Regulates Cigarette Smoke-Induced Proinflammatory Mediator Release Through Sirtuin 1-Nuclear Factor κB Axis in Macrophages and Mice Lungs.Pathobiology. 2019;86(5-6):237-247. doi: 10.1159/000500628. Epub 2019 Jun 26. Pathobiology. 2019. PMID: 31242482
-
Nucleosides isolated from Ophiocordyceps sinensis inhibit cigarette smoke extract-induced inflammation via the SIRT1-nuclear factor-κB/p65 pathway in RAW264.7 macrophages and in COPD mice.Int J Chron Obstruct Pulmon Dis. 2018 Sep 10;13:2821-2832. doi: 10.2147/COPD.S172579. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30237706 Free PMC article.
-
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.Cell Signal. 2013 Oct;25(10):1939-48. doi: 10.1016/j.cellsig.2013.06.007. Epub 2013 Jun 11. Cell Signal. 2013. PMID: 23770291 Review.
-
Redox regulation of SIRT1 in inflammation and cellular senescence.Free Radic Biol Med. 2013 Aug;61:95-110. doi: 10.1016/j.freeradbiomed.2013.03.015. Epub 2013 Mar 27. Free Radic Biol Med. 2013. PMID: 23542362 Free PMC article. Review.
Cited by
-
Immunological Insights into Cigarette Smoking-Induced Cardiovascular Disease Risk.Cells. 2022 Oct 11;11(20):3190. doi: 10.3390/cells11203190. Cells. 2022. PMID: 36291057 Free PMC article. Review.
-
Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy.Acta Pharmacol Sin. 2012 Jul;33(7):888-96. doi: 10.1038/aps.2012.73. Epub 2012 Jun 18. Acta Pharmacol Sin. 2012. PMID: 22705731 Free PMC article.
-
Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.PLoS One. 2011;6(11):e27081. doi: 10.1371/journal.pone.0027081. Epub 2011 Nov 1. PLoS One. 2011. PMID: 22069489 Free PMC article.
-
Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1.Cell Death Dis. 2014 Oct 2;5(10):e1432. doi: 10.1038/cddis.2014.406. Cell Death Dis. 2014. PMID: 25275593 Free PMC article.
-
Progress in the mechanism and targeted drug therapy for COPD.Signal Transduct Target Ther. 2020 Oct 27;5(1):248. doi: 10.1038/s41392-020-00345-x. Signal Transduct Target Ther. 2020. PMID: 33110061 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical